Brief: GlobeImmune reports Q3 net loss of $6.4 mln

GlobeImmune

12/11/2014 11:30

Nov 12 (Reuters) - GlobeImmune Inc  GBIM.O : 
 * Announces third quarter 2014 financial results 
 * Says expecting data from the first phase 2 trial of gs-4774 in the first half 
   of next year 
 * Reported net loss of $6.4 million in three months ended September 30 versus 
   net loss of $0.7 million for same period in 2013 
 * Says at September 30, 2014, GlobeImmune had cash and equivalents of $18.9 
   million 
 * Company believes that existing cash and cash equivalents will allow the 
   company to fund operations through 2015 
 
 * Source text for Eikon  ID:nMKWXMQJWa  
 
 * Further company coverage  GBIM.O   
 
 ((Bangalore Newsroom; +1 646 223 8780))